A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma

Author:

Cortese Matthew J.1,Wei Wei2,Cerdeña Sebastian3,Watkins Marcus P.3ORCID,Olson Marissa3,Jodon Gray4,Kaiser Jeff4,Haverkos Bradley4,Hughes Mitchell E.5,Namoglu Esin5,Grover Natalie S.6ORCID,Snow Anson6,Orellana-Noia Victor7,Rainey Magdalena8,Sohail Mohammad8,Rudoni Joslyn9,Portell Craig7,Voorhees Timothy6ORCID,Landsburg Daniel J.5,Kamdar Manali4,Kahl Brad S.3,Hill Brian T.1

Affiliation:

1. Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, OH, USA

2. Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Lerner Research Institute, Cleveland, OH, USA

3. Barnes-Jewish Hospital, Washington University in St. Louis, St. Louis, MO, USA

4. University of Colorado Cancer Center, Aurora, CO, USA

5. Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA

6. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA

7. Division of Hematology/Oncology, University of Virginia, Charlottesville, VA, USA

8. Lerner College of Medicine, Cleveland Clinic, Cleveland, OH, USA

9. Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3